{"id":2027,"date":"2021-01-25T20:43:57","date_gmt":"2021-01-25T18:43:57","guid":{"rendered":"http:\/\/interchem.epicstation.com\/product\/rivastigmine_ic\/"},"modified":"2021-02-18T19:04:23","modified_gmt":"2021-02-18T17:04:23","slug":"rivastigmine_ic","status":"publish","type":"product","link":"https:\/\/interchem.ua\/en\/product\/rivastigmine_ic\/","title":{"rendered":"Rivastigmine IC"},"content":{"rendered":"
Rivastigmine is an inhibitor of acetylcholinesterase and carbamate-type butyrylcholinesterase, which promotes cholinergic neurotransmission, slowing down the degradation of acetylcholine, which is released by functionally intact cholinergic neurons. Thus, rivastigmine has a beneficial effect on cognitive deficits due to impaired cholinergic neurotransmission, with dementia associated with Alzheimer’s disease or Parkinson’s disease.<\/span><\/span><\/span><\/span><\/p>\n The medicine is used for symptomatic treatment from mild to moderate dementia due to Alzheimer’s disease, as well as moderate to moderate dementia in patients with idiopathic Parkinson’s disease.<\/span><\/span><\/span><\/span><\/p>\n Trade name:<\/span><\/strong><\/span><\/span> Rivastigmine \u0406\u0421 Rivastigmine is an inhibitor of acetylcholinesterase and carbamate-type butyrylcholinesterase, which promotes cholinergic neurotransmission, slowing down the degradation of acetylcholine, which is released by functionally intact cholinergic neurons. Thus, rivastigmine has a beneficial effect on cognitive deficits due to impaired cholinergic neurotransmission, with dementia associated with Alzheimer’s disease or Parkinson’s disease. The medicine is used for […]<\/p>\n","protected":false},"featured_media":1942,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false},"product_cat":[33],"product_tag":[104],"class_list":{"0":"post-2027","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-drugs-en","7":"product_tag-r","9":"first","10":"instock","11":"product-type-simple"},"acf":[],"yoast_head":"\n
<\/span><\/span><\/span><\/span><\/span>Pharmaceutical form: <\/strong><\/span><\/span>capsules
<\/span><\/span>Pharmacotherapeutic group:<\/strong><\/span><\/span> Psychoanaleptics. Drugs used for dementia. Cholinesterase inhibitors. Rivastigmine.
ATX Code N06D A03.
<\/span><\/span>Registration number: <\/strong><\/span><\/span>\u2116<\/span><\/span>UA\/16388\/01\/01, <\/span><\/span>\u2116<\/span><\/span>UA\/16388\/01\/02, <\/span><\/span>\u2116<\/span><\/span>UA\/16388\/01\/03, <\/span><\/span>\u2116<\/span><\/span>UA\/16388\/01\/04
<\/span><\/span>Date of registration \/ valid until: <\/strong><\/span><\/span>25.10.2017 \/ 25.10.2022
<\/span><\/span>Packing:<\/strong><\/span><\/span> capsules <\/span><\/span>\u2116<\/span><\/span>30 (10 × 3) in a blister, in a pack
<\/span><\/span>Shelf life: <\/strong><\/span><\/span>2 years
<\/span><\/span>Legal <\/strong><\/span><\/span>\u0441<\/strong><\/span><\/span>ategory: <\/strong><\/span><\/span>p<\/span><\/span><\/span>rescription only medicine<\/p>\n
<\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"